This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
2924 Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: An exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study. (September 2015)
Record Type:
Journal Article
Title:
2924 Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: An exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study. (September 2015)
Main Title:
2924 Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: An exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study